328 related articles for article (PubMed ID: 33499388)
21. Rapid assays for lectin toxicity and binding changes that reflect altered glycosylation in mammalian cells.
Stanley P; Sundaram S
Curr Protoc Chem Biol; 2014 Jun; 6(2):117-133. PubMed ID: 24903886
[TBL] [Abstract][Full Text] [Related]
22. Glycan profiling of proteins using lectin binding by Surface Plasmon Resonance.
Wang W; Soriano B; Chen Q
Anal Biochem; 2017 Dec; 538():53-63. PubMed ID: 28947169
[TBL] [Abstract][Full Text] [Related]
23. Turning-Off Signaling by Siglecs, Selectins, and Galectins: Chemical Inhibition of Glycan-Dependent Interactions in Cancer.
Cagnoni AJ; Pérez Sáez JM; Rabinovich GA; Mariño KV
Front Oncol; 2016; 6():109. PubMed ID: 27242953
[TBL] [Abstract][Full Text] [Related]
24. Glycan-Gold Nanoparticles as Multifunctional Probes for Multivalent Lectin-Carbohydrate Binding: Implications for Blocking Virus Infection and Nanoparticle Assembly.
Budhadev D; Poole E; Nehlmeier I; Liu Y; Hooper J; Kalverda E; Akshath US; Hondow N; Turnbull WB; Pöhlmann S; Guo Y; Zhou D
J Am Chem Soc; 2020 Oct; 142(42):18022-18034. PubMed ID: 32935985
[TBL] [Abstract][Full Text] [Related]
25. Glycans in melanoma: Drivers of tumour progression but sweet targets to exploit for immunotherapy.
Niveau C; Sosa Cuevas E; Saas P; Aspord C
Immunology; 2024 May; ():. PubMed ID: 38742251
[TBL] [Abstract][Full Text] [Related]
26. Nanotechnological strategies for therapeutic targeting of tumor vasculature.
Ding Y; Li S; Nie G
Nanomedicine (Lond); 2013 Jul; 8(7):1209-22. PubMed ID: 23837858
[TBL] [Abstract][Full Text] [Related]
27. Aberrant glycosylation as biomarker for cancer: focus on CD43.
Tuccillo FM; de Laurentiis A; Palmieri C; Fiume G; Bonelli P; Borrelli A; Tassone P; Scala I; Buonaguro FM; Quinto I; Scala G
Biomed Res Int; 2014; 2014():742831. PubMed ID: 24689054
[TBL] [Abstract][Full Text] [Related]
28. Bitter-sweet symphony: glycan-lectin interactions in virus biology.
Van Breedam W; Pöhlmann S; Favoreel HW; de Groot RJ; Nauwynck HJ
FEMS Microbiol Rev; 2014 Jul; 38(4):598-632. PubMed ID: 24188132
[TBL] [Abstract][Full Text] [Related]
29. Surface glycan targeting for cancer nano-immunotherapy.
Choi Y; Kim J; Chae J; Hong J; Park J; Jeong E; Kim H; Tanaka M; Okochi M; Choi J
J Control Release; 2022 Feb; 342():321-336. PubMed ID: 34998918
[TBL] [Abstract][Full Text] [Related]
30. Glycobiology of cellular expiry: Decrypting the role of glycan-lectin regulatory complex and therapeutic strategies focusing on cancer.
Kumar Das A; Ghosh N; Mandal A; Sil PC
Biochem Pharmacol; 2023 Jan; 207():115367. PubMed ID: 36481348
[TBL] [Abstract][Full Text] [Related]
31. Peptide mimotopes to emulate carbohydrates.
Matsubara T
Chem Soc Rev; 2022 Oct; 51(19):8160-8173. PubMed ID: 36128765
[TBL] [Abstract][Full Text] [Related]
32. Nanoparticle-aided glycovariant assays to bridge biomarker performance and ctDNA results.
Gidwani K; Kekki H; Terävä J; Soukka T; Sundfeldt K; Pettersson K
Mol Aspects Med; 2020 Apr; 72():100831. PubMed ID: 31787337
[TBL] [Abstract][Full Text] [Related]
33. Lectin biosensors in cancer glycan biomarker detection.
Silva MLS
Adv Clin Chem; 2019; 93():1-61. PubMed ID: 31655728
[TBL] [Abstract][Full Text] [Related]
34. Glycan expression profile of signet ring cell gastric cancer cells and potential applicability of rBC2LCN-targeted lectin drug conjugate therapy.
Yang Y; Akashi Y; Shimomura O; Tateno H; Saito S; Hiemori K; Miyazaki Y; Furuta T; Kitaguchi D; Kuroda Y; Pakavarin L; Oda T
Gastric Cancer; 2022 Sep; 25(5):896-905. PubMed ID: 35715659
[TBL] [Abstract][Full Text] [Related]
35. The detection and discovery of glycan motifs in biological samples using lectins and antibodies: new methods and opportunities.
Tang H; Hsueh P; Kletter D; Bern M; Haab B
Adv Cancer Res; 2015; 126():167-202. PubMed ID: 25727148
[TBL] [Abstract][Full Text] [Related]
36. Rapid On-Chip Synthesis of Complex Glycomimetics from N-Glycan Scaffolds for Improved Lectin Targeting.
Cioce A; Thépaut M; Fieschi F; Reichardt NC
Chemistry; 2020 Oct; 26(56):12809-12817. PubMed ID: 32445493
[TBL] [Abstract][Full Text] [Related]
37. Detection of distinct glycosylation patterns on human γ-glutamyl transpeptidase 1 using antibody-lectin sandwich array (ALSA) technology.
West MB; Partyka K; Feasley CL; Maupin KA; Goppallawa I; West CM; Haab BB; Hanigan MH
BMC Biotechnol; 2014 Dec; 14():101. PubMed ID: 25479762
[TBL] [Abstract][Full Text] [Related]
38. The use of lectin microarray for assessing glycosylation of therapeutic proteins.
Zhang L; Luo S; Zhang B
MAbs; 2016; 8(3):524-35. PubMed ID: 26918373
[TBL] [Abstract][Full Text] [Related]
39. Comparison of orthogonal chromatographic and lectin-affinity microarray methods for glycan profiling of a therapeutic monoclonal antibody.
Cook MC; Kaldas SJ; Muradia G; Rosu-Myles M; Kunkel JP
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Aug; 997():162-78. PubMed ID: 26114652
[TBL] [Abstract][Full Text] [Related]
40. Focused differential glycan analysis with the platform antibody-assisted lectin profiling for glycan-related biomarker verification.
Kuno A; Kato Y; Matsuda A; Kaneko MK; Ito H; Amano K; Chiba Y; Narimatsu H; Hirabayashi J
Mol Cell Proteomics; 2009 Jan; 8(1):99-108. PubMed ID: 18697734
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
